IN2014DN06817A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN06817A IN2014DN06817A IN6817DEN2014A IN2014DN06817A IN 2014DN06817 A IN2014DN06817 A IN 2014DN06817A IN 6817DEN2014 A IN6817DEN2014 A IN 6817DEN2014A IN 2014DN06817 A IN2014DN06817 A IN 2014DN06817A
- Authority
- IN
- India
- Prior art keywords
- support member
- macropores
- biologies
- delivery
- certain embodiments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261588312P | 2012-01-19 | 2012-01-19 | |
| PCT/US2013/022057 WO2013109825A1 (fr) | 2012-01-19 | 2013-01-18 | Matériaux chromatographiques pour le stockage et la délivrance d'agents biologiques thérapeutiques et de petites molécules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06817A true IN2014DN06817A (fr) | 2015-05-22 |
Family
ID=48797397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6817DEN2014 IN2014DN06817A (fr) | 2012-01-19 | 2013-01-18 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20130189322A1 (fr) |
| EP (1) | EP2804634B1 (fr) |
| JP (2) | JP6552822B2 (fr) |
| KR (1) | KR102113296B1 (fr) |
| AU (1) | AU2013209620B2 (fr) |
| CA (2) | CA2861932C (fr) |
| DK (1) | DK2804634T3 (fr) |
| ES (1) | ES2750211T3 (fr) |
| IN (1) | IN2014DN06817A (fr) |
| WO (1) | WO2013109825A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014058570A1 (fr) | 2012-09-17 | 2014-04-17 | Alltech Associates, Inc. | Milieu de chromatographie et dispositifs associés |
| WO2015013542A1 (fr) | 2013-07-25 | 2015-01-29 | Bio-Rad Laboratories, Inc. | Fonctionnalité et libération de protéine à partir d'un substrat poreux |
| FR3012978A1 (fr) * | 2013-11-12 | 2015-05-15 | Biocarecell | Filtre biocompatible et procede de fabrication d'un filtre biocompatible. |
| JP6853670B2 (ja) | 2014-01-16 | 2021-04-07 | ダブリュー・アール・グレース・アンド・カンパニー−コーンＷ Ｒ Ｇｒａｃｅ ＆ Ｃｏ−Ｃｏｎｎ | 親和性クロマトグラフィー媒体及びクロマトグラフィーデバイス |
| JP6914189B2 (ja) | 2014-05-02 | 2021-08-04 | ダブリュー・アール・グレース・アンド・カンパニー−コーンＷ Ｒ Ｇｒａｃｅ ＆ Ｃｏ−Ｃｏｎｎ | 官能化担体材料並びに官能化担体材料を作製及び使用する方法 |
| IS3008B (is) * | 2014-05-14 | 2018-12-15 | Calor ehf | Stöðgandi lausnir fyrir prótín og peptíð |
| ES2896897T3 (es) | 2015-06-05 | 2022-02-28 | Grace W R & Co | Agentes de clarificación para el bioprocesamiento de adsorbentes y métodos para producir y usar los mismos |
| US20210379186A1 (en) * | 2018-04-16 | 2021-12-09 | Merck Patent Gmbh | Additives for protein formulations to improve thermal stability |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059654A (en) * | 1983-02-14 | 1991-10-22 | Cuno Inc. | Affinity matrices of modified polysaccharide supports |
| DE3682047D1 (de) * | 1985-07-09 | 1991-11-21 | Quadrant Bioresources Ltd | Beschuetzung von proteinen und aehnlichem. |
| US5492821A (en) * | 1990-11-14 | 1996-02-20 | Cargill, Inc. | Stabilized polyacrylic saccharide protein conjugates |
| US5159049A (en) * | 1991-04-22 | 1992-10-27 | Allen Robert C | Method for stabilizing polyacrylamide gels |
| US5583162A (en) * | 1994-06-06 | 1996-12-10 | Biopore Corporation | Polymeric microbeads and method of preparation |
| US6284282B1 (en) * | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
| SE9904475D0 (sv) * | 1999-12-08 | 1999-12-08 | Artursson | Nucleic acid delivery system |
| US6896894B2 (en) * | 2001-10-30 | 2005-05-24 | Battelle Memorial Institute | Proteins stabilized with polysaccharide gums |
| AU2003217367B2 (en) * | 2002-02-08 | 2005-09-08 | Alkermes Controlled Therapeutics, Inc. | Polymer-based compositions for sustained release |
| US6666281B2 (en) | 2002-03-19 | 2003-12-23 | Deere & Company | Bearing guard for a ground-working implement |
| US20040137004A1 (en) * | 2002-03-19 | 2004-07-15 | Glenn Gregory M | Patch for transcutaneous immunization |
| WO2004073843A1 (fr) | 2003-02-19 | 2004-09-02 | Mcmaster University | Materiaux composites porteur de gels poreux |
| US7785769B2 (en) * | 2003-07-25 | 2010-08-31 | The United States of America as reprsented by the Secretary of the Navy | Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| EP1758671B9 (fr) | 2004-04-08 | 2014-02-19 | Natrix Separations Inc. | Empilements de membranes |
| JP2008509226A (ja) * | 2004-05-24 | 2008-03-27 | ジェンボールト コーポレイション | 回収可能な形式での安定なタンパク質保管および安定な核酸保管 |
| WO2005120701A1 (fr) * | 2004-06-07 | 2005-12-22 | Mcmaster University | Materiau composite stable comprenant des gels poreux supportes |
-
2013
- 2013-01-18 IN IN6817DEN2014 patent/IN2014DN06817A/en unknown
- 2013-01-18 JP JP2014553432A patent/JP6552822B2/ja active Active
- 2013-01-18 CA CA2861932A patent/CA2861932C/fr active Active
- 2013-01-18 AU AU2013209620A patent/AU2013209620B2/en active Active
- 2013-01-18 WO PCT/US2013/022057 patent/WO2013109825A1/fr active Application Filing
- 2013-01-18 DK DK13739077T patent/DK2804634T3/da active
- 2013-01-18 US US13/744,583 patent/US20130189322A1/en not_active Abandoned
- 2013-01-18 EP EP13739077.9A patent/EP2804634B1/fr active Active
- 2013-01-18 CA CA3124806A patent/CA3124806C/fr active Active
- 2013-01-18 ES ES13739077T patent/ES2750211T3/es active Active
- 2013-01-18 KR KR1020147022518A patent/KR102113296B1/ko active IP Right Grant
-
2018
- 2018-09-20 JP JP2018175774A patent/JP2019011341A/ja active Pending
-
2019
- 2019-09-04 US US16/560,370 patent/US20200069602A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2861932A1 (fr) | 2013-07-27 |
| CA3124806A1 (fr) | 2013-07-27 |
| JP2015504092A (ja) | 2015-02-05 |
| EP2804634A4 (fr) | 2015-07-22 |
| AU2013209620A1 (en) | 2014-08-28 |
| ES2750211T3 (es) | 2020-03-25 |
| CA2861932C (fr) | 2021-09-14 |
| CA3124806C (fr) | 2023-09-26 |
| US20200069602A1 (en) | 2020-03-05 |
| JP6552822B2 (ja) | 2019-07-31 |
| WO2013109825A1 (fr) | 2013-07-25 |
| EP2804634A1 (fr) | 2014-11-26 |
| EP2804634B1 (fr) | 2019-08-28 |
| JP2019011341A (ja) | 2019-01-24 |
| KR102113296B1 (ko) | 2020-06-02 |
| DK2804634T3 (da) | 2019-11-04 |
| KR20140117529A (ko) | 2014-10-07 |
| US20130189322A1 (en) | 2013-07-25 |
| AU2013209620B2 (en) | 2017-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN06817A (fr) | ||
| HK1212890A1 (zh) | 生物活性分子、其偶聯物及治療用途 | |
| MX2015012933A (es) | Micrordenamiento para suministro de agente terapeutico y metodos de uso. | |
| MD20160079A2 (ro) | Sistem de livrare a medicamentului | |
| HK1211467A1 (en) | Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes il-15r alpha il-15r alpha il-15r alpha il-15/ il-15r alpha | |
| DK2925272T3 (da) | Lægemiddelopbevarings-, udleverings- og administrationssystem | |
| PH12019550145A1 (en) | Physiologically active substance carrier | |
| MX365612B (es) | Polipeptidos de factor x modificados y usos de los mismos. | |
| MY156697A (en) | Modified tuberculosis antigens | |
| HK1243718A1 (zh) | Fgfr3融合基因和以其作為標靶的藥物 | |
| WO2013028942A8 (fr) | Ciblage de microbulles | |
| MX2016014622A (es) | Sistemas de suministro de medicamentos y metodos de uso relacionados. | |
| PH12018500826A1 (en) | Extracorporeal life support system and methods of use thereof | |
| EP3007668A4 (fr) | Unité d'hôpital de support de patient, système de transport de patient et système de transport et de réanimation de patient | |
| HK1220109A1 (zh) | 含卡巴拉汀的經皮給藥系統 | |
| IL226205B (en) | Fusion proteins, pharmaceutical preparations containing them and their use in the preparation of drugs for the treatment of cancer | |
| WO2013016578A3 (fr) | Libération contrôlée de produits biopharmaceutiques oculaires au moyen de polymères protéiques biosensibles | |
| MX2014012164A (es) | Composiciones a base de probioticos y un complejo de polen de abejas/arcilla, su preparacion y sus usos en nutricion y en terapeutica. | |
| HK1255501A1 (zh) | 胺羧基硼烷作為一氧化碳的治療性輸送和作為活性氧存在下的一般藥物輸送系統的用途 | |
| SG11201501917SA (en) | Composite hydrogels for delivery of biologically active materials | |
| PL3303215T3 (pl) | Układ pallad-platyna do zastosowania jako materiał do magazynowania wodoru i/lub elektrokatalizator, korzystnie w ogniwach paliwowych | |
| NZ702849A (en) | Genotype- or phenotype-based drug formulation | |
| EP2832370A4 (fr) | Procédé de production de produits médicamenteux et bioactifs | |
| UA74769U (ru) | Способ лечения больных со стеатозом печени, совмещенным с хроническим безкаменным холециститом | |
| MX2012006361A (es) | Materiales hibridos para tratar pacientes con ulceraciones en pie diabetico. |